
|Articles|August 1, 2011
Robotic radical prostatectomy patients may have lower PSA recurrence
An international study analyzing data from almost 30,000 men treated with radical prostatectomy as monotherapy for high-risk prostate cancer provides some evidence that short- to medium-term oncologic outcomes are better for men who undergo robot-assisted laparoscopic RP (RALP) compared with open RP (ORP) and laparoscopic RP (LRP).
Advertisement
Washington-An international study analyzing data from almost 30,000 men treated with radical prostatectomy as monotherapy for high-risk prostate cancer provides some evidence that short- to medium-term oncologic outcomes are better for men who undergo robot-assisted laparoscopic RP (RALP) compared with open RP (ORP) and laparoscopic RP (LRP).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
2
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
3
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
4
Optimizing care for men with overactive bladder, with Keith Xavier, MD
5








